SCHEMBL6370617

SCHEMBL6370617

PCC(c1ccccc1)N1CCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.62
CYP2C19 P33261 6/20 0.62
CYP3A4 P08684 5/20 0.62
CYP2D6 P10635 5/20 0.62
TSHR P16473 1/20 0.62
CYP2C9 P11712 5/20 0.58
HPGD P15428 1/20 0.58
MAPK1 P28482 1/20 0.58
KCNA5 P22460 4/20 0.55
KCNH2 Q12809 4/20 0.55
KCNE1 P15382 1/20 0.53
ALDH1A1 P00352 1/20 0.48
SLC6A4 P31645 3/20 0.46
SLC6A2 P23975 2/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
L3MBTL3 Q96JM7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
OPRL1 P41146 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10598753 0.81 OPRM1 (0.63) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL468998 0.80 CYP1A2 (0.62) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL1964502 0.80 CYP1A2 (0.62) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL15017817 0.80 CYP1A2 (0.62) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL8916036 0.80 CYP1A2 (0.62) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL3583059 0.80 OPRL1 (0.63) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL4957801 0.80 CYP1A2 (0.62) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL1205831 0.80 OPRL1 (0.63) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL8507420 0.80 OPRL1 (0.63) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL10601133 0.79 CYP1A2 (0.62) CYP1A2CYP2C19CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107608-A1 Ligands for use in catalytic processes EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH ETHZ (CH) 2005-05-19 US disclosed
EP-1448575-A1 LIGANDS FOR USE IN CATALYTIC PROCESSES Eidgenössische Technische Hochschule (ETH) Zürich (CH) 2004-08-25 EP disclosed
WO-2003048175-A1 LIGANDS FOR USE IN CATALYTIC PROCESSES EIDGENÖSSISCHE TECHNISCHE HOCHSCHULE ZÜRICH ETHZ (CH) 2003-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107608-A1 Ligands for use in catalytic processes PNKP, ITPA, PLCG2 CYP1A2 1400/4885CYP2C19 1778/4885CYP3A4 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.